share_log

HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target

HC Wainwright & Co.重申对狼人治疗公司买入评级,维持15美元价格目标。
Benzinga ·  06/03 10:14

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15 price target.

HC Wainwright & Co. 分析师Andres Maldonado重申对Werewolf Therapeutics (纳斯达克代码: HOWL)的买入评级,维持股价目标为15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发